N-[(3-methoxyphenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
Chemical Structure Depiction of
N-[(3-methoxyphenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
N-[(3-methoxyphenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide
Compound characteristics
Compound ID: | G640-0616 |
Compound Name: | N-[(3-methoxyphenyl)methyl]-2-[3-methyl-4-oxo-7-(pyrrolidine-1-sulfonyl)-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]acetamide |
Molecular Weight: | 503.64 |
Molecular Formula: | C24 H29 N3 O5 S2 |
Smiles: | CC1CSc2ccc(cc2N(CC(NCc2cccc(c2)OC)=O)C1=O)S(N1CCCC1)(=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 3.2534 |
logD: | 3.2534 |
logSw: | -3.775 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 79.764 |
InChI Key: | COUSLOUGMCMESG-QGZVFWFLSA-N |